Central Park Hematology and Oncology — New York, New York

Central Park Hematology and Oncology is a clinical research site located in New York, New York, United States 10028-0506.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Central Park Hematology and Oncology has participated in 1 clinical trials.

Therapeutic areas: Advanced Unresectable or Metastatic Solid Malignancy.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Park Hematology and Oncology?

Central Park Hematology and Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Park Hematology and Oncology conducted?

Central Park Hematology and Oncology has 1 clinical trials on record. Their work covers Advanced Unresectable or Metastatic Solid Malignancy.

Is Central Park Hematology and Oncology accredited by Crixeo Health?

Central Park Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Park Hematology and Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.